3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Multiple Myeloma
116
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Recurrence
17
Burkitt Lymphoma
16
Neoplasms
8
Lymphoma, Large B-Cell, Diffuse
8
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
7
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
6
Neoplasms, Plasma Cell
6
Lymphoma
6
Leukemia, Biphenotypic, Acute
6
Immunoglobulin Light-chain Amyloidosis
5
Carcinoma, Non-Small-Cell Lung
5
Prostatic Neoplasms
4
Lymphoma, Non-Hodgkin
4
Lymphoma, B-Cell
4
Waldenstrom Macroglobulinemia
3
Neoplasm Metastasis
3
Nausea
3
Lung Neoplasms
3
Leukemia
3
Down Syndrome
3
Smoldering Multiple Myeloma
2
Rectal Neoplasms
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Paraproteinemias
2
Ovarian Neoplasms
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Interventions
Etoposide
31
Carboplatin
30
durvalumab
17
atezolizumab
17
Cisplatin
14
Topotecan
11
PM 01183
11
Specimen Handling
9
Magnetic Resonance Spectroscopy
7
pembrolizumab
6
olaparib
5
berzosertib
4
anlotinib
4
Radiotherapy
4
Paclitaxel
4
Nivolumab
4
Irinotecan
4
Drug Therapy
4
AMG 757
4
tremelimumab
3
toripalimab
3
tislelizumab
3
Injections
3
Docetaxel
3
Biopsy
3
Bevacizumab
3
sacituzumab govitecan
2
monalizumab
2
cabozantinib
2
Temozolomide
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Small Cell Lung Carcinoma
×
Dexamethasone
×
90 days
×
Clear all
No trials found.